Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani

Visceral leishmaniasis (VL) is associated with treatment complications due to the continued growth of resistant parasites toward currently available pathogen-directed therapeutics. To limit the emergence and combat resistant parasites there is a need to develop new anti-leishmanial drugs and alterna...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Parasitol Drugs Drug Resist
Main Authors: Zahid, M. Shamim Hasan, Johnson, Monica M., Tokarski, Robert J., Satoskar, Abhay R., Fuchs, James R., Bachelder, Eric M., Ainslie, Kristy M.
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731340/
https://ncbi.nlm.nih.gov/pubmed/31493763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2019.08.004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares